These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6905641)
41. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat. Wang C; Ford P; Chao C; Chao L; Chao J Am J Physiol; 1997 Nov; 273(5):F783-9. PubMed ID: 9374842 [TBL] [Abstract][Full Text] [Related]
42. Effects of kallidinogenase on urinary kallikrein excretion and plasma prostanoid concentrations in patients with essential hypertension. Ogawa K; Ito T; Ban M; Motizuki M; Satake T Experientia; 1986 Sep; 42(9):1014-5. PubMed ID: 3639011 [TBL] [Abstract][Full Text] [Related]
43. Changes in urinary tissue kallikrein excretion in black African women with hypertensive disorders of pregnancy. Khedun SM; Naicker T; Moodley J; Naidoo S; Bhoola KD Immunopharmacology; 1997 Jun; 36(2-3):243-7. PubMed ID: 9228553 [TBL] [Abstract][Full Text] [Related]
44. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats. Emond C; Bompart G; Rakotoarivony J; Bascands JL; Pecher C; Adam A; Tarrade T; Berthet P; Girolami JP J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717 [TBL] [Abstract][Full Text] [Related]
45. Urinary kallikrein excretion can predict the blood pressure response to a single oral dose of captopril. Madeddu P; Oppes M; Rubattu S; Bandiera F; Dessi'-Fulgheri P; Glorioso N; Soro A; Chiara-Troffa M; Rappelli A Agents Actions Suppl; 1987; 22():321-8. PubMed ID: 3324715 [TBL] [Abstract][Full Text] [Related]
46. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans. Ohman KP; Karlberg BE Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330 [TBL] [Abstract][Full Text] [Related]
47. The renal kallikrein-kinin system in human and in experimental hypertension. Carretero OA; Scicli AG Klin Wochenschr; 1978; 56 Suppl 1():113-25. PubMed ID: 366276 [TBL] [Abstract][Full Text] [Related]
48. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension. Rey C; Santos F; Málaga S; Orejas G; Simarro M; Crespo M J Cardiovasc Risk; 1995 Apr; 2(2):143-8. PubMed ID: 7606651 [TBL] [Abstract][Full Text] [Related]
49. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases. Shimamoto K; Ura N; Tanaka S; Ogasawara A; Nakao T; Nakahashi Y; Chao J; Margolius HS; Iimura O Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609 [TBL] [Abstract][Full Text] [Related]
50. Urinary kallikrein activity in the hypertension of renal parenchymal disease. Mitas JA; Levy SB; Holle R; Frigon RP; Stone RA N Engl J Med; 1978 Jul; 299(4):162-5. PubMed ID: 661889 [TBL] [Abstract][Full Text] [Related]
51. Reduced ratio of active-to-total urinary kallikrein in essential hypertension. Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366 [TBL] [Abstract][Full Text] [Related]
52. Developmental patterns of blood pressure and urinary protein, kallikrein, and prostaglandin E2 in Dahl salt-hypertension-susceptible rats. Sustarsic DL; McPartland RP; Rapp JP J Lab Clin Med; 1981 Oct; 98(4):599-606. PubMed ID: 6912875 [TBL] [Abstract][Full Text] [Related]
53. The renal kallikrein-kinin system in spontaneously hypertensive rats. Bönner G; Unger T; Rascher W; Speck G; Ganten D; Gross F Agents Actions; 1984 Oct; 15(3-4):111-8. PubMed ID: 6570082 [TBL] [Abstract][Full Text] [Related]
54. The role of urinary kininogen in the regulation of kinin generation. Weinberg MS; Azar P; Trebbin WM; Solomon RJ Kidney Int; 1985 Dec; 28(6):975-81. PubMed ID: 3910918 [TBL] [Abstract][Full Text] [Related]
55. Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria. Ardiles LG; Loyola F; Ehrenfeld P; Burgos ME; Flores CA; Valderrama G; Caorsi I; Egido J; Mezzano SA; Figueroa CD Kidney Int; 2006 Jan; 69(1):53-9. PubMed ID: 16374423 [TBL] [Abstract][Full Text] [Related]
56. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats. Wang C; Chao C; Chen LM; Chao L; Chao J Am J Physiol; 1996 Oct; 271(4 Pt 2):F824-30. PubMed ID: 8898012 [TBL] [Abstract][Full Text] [Related]
57. Urinary kallikrein activity is not altered in human essential hypertension. Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922 [TBL] [Abstract][Full Text] [Related]
58. [Salt-dependence of blood pressure and urinary kallikrein excretion in essential hypertension (author's transl)]. Kojima S; Ito K; Sakaguchi A; Kimura G; Uda M; Kuroda K; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T; Satani M; Ikeda M Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1105-12. PubMed ID: 6915133 [No Abstract] [Full Text] [Related]
59. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367 [TBL] [Abstract][Full Text] [Related]
60. Lack of oral kallikrein in lowering systemic blood pressure in primary hypertension. Bönner G; Toussaint C; Claus M; Fritschka E; Philipp T; Vetter H; Feltkamp H Agents Actions Suppl; 1992; 38 ( Pt 3)():294-303. PubMed ID: 1462864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]